Skip to main content
S.Biomedics Co., Ltd. logo

S.Biomedics Co., Ltd. — Investor Relations & Filings

Ticker · 304360 ISIN · KR7304360001 KO Professional, scientific and technical activities
Open in API
Filings indexed 138 across all filing types
Latest filing 2024-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 304360

About S.Biomedics Co., Ltd.

https://www.sbiomedics.com/eng/

S.Biomedics Co., Ltd. is a company specializing in the research and development of cell therapies for regenerative medicine. Established in 2005, the company focuses on creating, manufacturing, and supplying stem cell-based therapeutic products. Its core activities involve leveraging data-driven biology to develop fundamental and safe treatments for various conditions, with a significant focus on neurodegenerative disorders such as Parkinson's disease. S.Biomedics is committed to advancing the field of stem cell therapy from initial research to clinical application.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for S-Biomedics. It details the meeting date, location, agenda items (such as approval of financial statements, election of directors, and remuneration limits), and provides background information for shareholders to review before the meeting. This document is a standard proxy statement/notice of meeting sent to shareholders to solicit their participation and votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by S-Biomedics. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, director/auditor compensation, and the election of board members. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items for voting purposes.
2024-02-22 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company must hold its AGM on a date that coincides with other companies' meetings. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2024-02-22 Korean
매출액또는손익구조30%(대규모법인은15%)미만변동(자율공시)
Earnings Release Classification · 100% confidence The document is a regulatory filing from S-Biomedics regarding a change in revenue or profit/loss structure (less than 30%). It provides a summary table of financial data (revenue, operating profit, net income) comparing the current fiscal year to the previous one, along with the reasons for the change. This is a standard periodic financial disclosure announcement in the Korean market (DART system), which fits the 'Earnings Release' (ER) category as it provides key financial highlights before the full audit is finalized. FY 2023
2024-02-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure of insider trading or changes in share ownership by company directors and major shareholders. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2023-12-18 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2023-12-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.